Risk factors associated with temporomandibular joint disorder: A mendelian randomization analysis

Q Yan, L Liao, D He - Journal of Oral Rehabilitation, 2024 - Wiley Online Library
Background Temporomandibular joint disorder (TMD), a prevalent orofacial disorder with
complex aetiologies and considerable socioeconomic costs. This underscores the critical …

A Systematic Literature Review on Inflammatory Markers in the Saliva of Patients with Multiple Sclerosis: A Cause or a Consequence of Periodontal Diseases

VC Arcas, IA Tig, DFC Moga, AL Vlad, C Roman-Filip… - Medicina, 2024 - mdpi.com
Background and Objectives: Multiple sclerosis (MS) is a chronic neurodegenerative disease
often linked with systemic conditions such as periodontal diseases (PDs). This systematic …

The Development of the Combination Drug Leukovir® Tablets for the Treatment of Multiple Sclerosis: A Comprehensive Review

EN Kalinichenko, SV Babitskaya - Current Drug Targets, 2023 - ingentaconnect.com
Introduction: Rosa webbiana (RW) Wall Ex. Royle is used in traditional medicine in Pakistan
for the treatment of several diseases including jaundice. To date, only neuroprotective …

Chronic periodontitis in a patient with multiple sclerosis—A case report

R Tavajohi, A Sarbaz, H Honarmand… - Clinical Case …, 2024 - pmc.ncbi.nlm.nih.gov
Key Clinical Message Multiple sclerosis (MS) is one of the common central nervous system
diseases, but it can cause dysfunction in other organs such as periodontal tissues. However …

Segmentation and evaluation of multiple sclerosis in flair modality MRI with ResUNet

M Rajasekar, A Mukil, R Lakshamanan - AIP Conference Proceedings, 2024 - pubs.aip.org
One of the most prevalent autoimmune diseases that can affect the Central Nervous System
(CNS) in mild to severe ways is multiple sclerosis (MS). The goal of this study is to separate …

A real-world pharmacovigilance study of Ocrelizumab based on FAERS database

H Liang, J Wu, L Chen, Y Shen - 2024 - researchsquare.com
Ocrelizumab is a humanized monoclonal antibody targeting CD20 for the treatment of
multiple sclerosis (MS). The analysis of the FDA Adverse Event Reporting System database …

[PDF][PDF] Assessment of oral health literacy and DMFT index score in multiple sclerosis patients

F Feili, M Roozegar - ACADEMIC JOURNAL, 2025 - researchgate.net
Background: Multiple sclerosis (MS) is a chronic demyelinating disease that affects the
central nervous system. Objectives: The aim of this study was to investigate the oral health …

[引用][C] Penyakit Sistem Saraf

K Kuswanto, H Leniwita, RR Sinaga, MS Sari… - 2024 - Yayasan Kita Menulis